Tirzepatide 5MG or 10MG

Tirzepatide is a peptide originally developed for the treatment of type 2 diabetes and now used for weight loss. 

After 36 weeks of open-label maximum tolerated dose of tirzepatide, adults with obesity or overweight (without diabetes) experienced a mean weight reduction of 20.9%.

From randomization (at week 36), those switched to placebo experienced a 14% weight regain and those continuing tirzepatide experienced an additional 5.5% weight reduction during the 52-week double-blind period.